Clinical trials
Phase 3 Wet Macular Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Outlook Therapeutics, Inc. | 4 |
| Novartis Pharmaceuticals | 3 |
| 4D Molecular Therapeutics | 2 |
| Hoffmann-La Roche | 2 |
| AbbVie | 1 |
| Opthea Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wet Macular Degeneration | 13 |
| Macular Degeneration | 11 |
| Eye Diseases | 4 |
| Retinal Degeneration | 4 |
| Retinal Diseases | 4 |
| Choroidal Neovascularization | 3 |
| Geographic Atrophy | 2 |
| Retinal Vein Occlusion | 2 |
| Vision Disorders | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.